JUN 19, 2015 4:16 PM PDT

Surface Sampling Probe for Surgeons

WRITTEN BY: Ilene Schneider
An automated droplet-based surface sampling probe can help a surgeon to determine whether a patient's tissue is cancerous - while that patient is still on the operating table. Researchers from the Department of Energy's Oak Ridge National Laboratory and Brigham and Women's Hospital/Harvard Medical School say the tool cuts analysis time from 20 or 30 minutes to 10 minutes and expect to cut that number in half.
A new tool would let surgeons know if tissue is cancerous while the patient is still on the operating table.
According to an article in Analytical and Bioanalytical Chemistry that was reported in Science Daily, the mass spectrometry-based technology can be used in place of immunohistochemistry, or IHC, that searches looks for specific protein biomarkers to make a diagnosis. In the words of the article, "Although the IHC approach provides a high degree of spatial recognition, it is time consuming and limited by the quality and specificity of the antibody used to detect the protein"
(DOE/Oak Ridge National Laboratory. "New tool on horizon for surgeons treating cancer patients." ScienceDaily. ScienceDaily, 18 June 2015) (www.sciencedaily.com/releases/2015/06/150618145912.htm).

The team, led by ORNL's Vilmos Kertesz, profiled two hormones from human pituitary tissue. As Kertesz explained, "Instead of having to cut and mount tissue and wait for a trained pathologist to review the sample under a microscope, a technician might soon perform an equally conclusive test in the operating environment." The researchers based their work on patents from previously funded DOE projects and said that it advances the liquid microjunction surface sampling probe technology first patented by ORNL.

Other mass spectrometry-based techniques, including desorption electrospray ionization and rapid evaporative ionization mass spectrometry are being evaluated for classifying tumors and providing prognostic information, but they usually analyze lower molecular weight biomolecules such as metabolites, fatty acids and lipids. The droplet-based method developed at ORNL is not limited in this way. Thus, it can enhance surgical decision-making, Kertesz stated.

Kertesz and his colleagues have also used the fully automated droplet-based surface-sampling system for determining the distribution of drugs and their metabolites in rat thin tissue sections. Such analysis is based on the use of an autosampler coupled to HPLC/MS and capable of liquid-extraction based surface sampling. This system enables the analyst to work with complex sample matrices and to identify isomeric compounds not distinguishable by direct surface sampling methods alone (www.future-science.com/doi/abs/10.4155/bio.14.130).

"On the basis of the results and the relative simplicity, rapidity and specificity of our method, there is great potential for our technology to assist surgeons in the detection of cancer from tissue biopsy samples," said Kertesz, a member of ORNL's Organic and Biological Mass Spectrometry Group and lead author of the paper (http://oakridgetoday.com/2015/06/18/ornl-new-tool-on-horizon-for-surgeons-treating-cancer-patients/#more-57779).
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
OCT 09, 2020
Cancer
Cloud technology cuts improve efficiency for cancer nurses
OCT 09, 2020
Cloud technology cuts improve efficiency for cancer nurses
In a new study reported in Clinical Cancer Informatics, an American Society of Clinical Oncology journal, medical provid ...
OCT 14, 2020
Cancer
Research suggests statins could reduce the risk of cancer
OCT 14, 2020
Research suggests statins could reduce the risk of cancer
New research published in the journal eLife provides evidence that statins, the common cholesterol-lowering drugs, could ...
OCT 18, 2020
Microbiology
Mouth Microbes Play a Role in Oral Cancer Development
OCT 18, 2020
Mouth Microbes Play a Role in Oral Cancer Development
Oral hygiene is not only important for keeping teeth and gums healthy; it can also affect a person's health in general.
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 24, 2020
Clinical & Molecular DX
Young Inventor Creates Award-winning At-home Cancer Diagnostic
NOV 24, 2020
Young Inventor Creates Award-winning At-home Cancer Diagnostic
Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive proce ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
Loading Comments...